Format

Send to

Choose Destination
Crit Rev Oncol Hematol. 2013 Apr;86(1):33-41. doi: 10.1016/j.critrevonc.2012.09.010. Epub 2012 Oct 22.

Adjuvant radiotherapy in the management of axillary node negative invasive breast cancer: a qualitative systematic review.

Author information

1
Radiation Oncology Department, Institut Gustave Roussy, Villejuif, France. bourgier@igr.fr

Abstract

PURPOSE:

To actualize and to detail guidelines used in technical radiotherapy and indications for innovative radiation technologies in early axillary node negative breast cancer (BC).

METHODS:

Dosimetric and treatment planning studies, phase II and III trials, systematic reviews and retrospective studies were all searched (Medline(®) database). Their quality and clinical relevance were also checked against validated checklists. A level of evidence was associated for each result.

RESULTS:

A total of 75 references were included. Adjuvant BC radiotherapy (50Gy/25 fractions/5 weeks followed by a tumor boost of 16Gy/8 fractions) is still the standard of care. Overall treatment time could be shortened for patients who present with low local relapse risk BC by using either hypofractionated whole breast irradiation; or accelerated partial breast irradiation. BC IMRT is not used in current practice.

CONCLUSION:

Our group aimed to provide guidelines for technical and clinical applications of innovative BC radiation technologies.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center